Clinical Trials Logo
  1. Home
  2. Eczema
  3. NCT00484003

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

Atopic Eczema Clinical Trial

Official title:
A 3-Month Open Label, National, Quality of Life , and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years ) With Atopic Dermatitis

Clinical Trial Summary

The study will evaluate the safety and effect of pimecrolimus cream 1% on quality of life of caregivers of South African children with mild to moderate atopic dermatitis (AD).

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00484003
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 4
Start date October 2004
Completion date December 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT02381028 - Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children N/A
Recruiting NCT06230991 - A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema N/A
Completed NCT05454722 - A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema. N/A
Completed NCT01854580 - Evaluation of an Integrated Care Project
Completed NCT00555178 - Regulatory T Cells (Tregs) in Polymorphic Light Eruption N/A
Completed NCT00559546 - Montelukast as a Controller of Atopic Syndrome Phase 4
Completed NCT00224432 - Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis N/A
Active, not recruiting NCT03143504 - A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
Active, not recruiting NCT03409367 - A Community-based Assessment of Skin Care, Allergies, and Eczema N/A
Not yet recruiting NCT06453512 - A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema N/A
Completed NCT00826592 - Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis N/A
Completed NCT00576238 - Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser Phase 3
Active, not recruiting NCT05590585 - Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial Phase 4
Completed NCT01119313 - Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema Phase 2
Completed NCT00676884 - A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema Phase 2
Recruiting NCT03270566 - Softened Water for Eczema Prevention Pilot Trial N/A
Completed NCT02300701 - Role of Anti-IgE in Severe Childhood Eczema Phase 4
Completed NCT04114097 - The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover Phase 4
Completed NCT02915146 - Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema N/A
Recruiting NCT00771121 - Effect of Moisturizing Creams on Skin Barrier Function Phase 4